Articles producció científica> Medicina i Cirurgia

The Impact of Dietary Interventions on Metabolic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Comorbid Conditions, Including Obesity and Type 2 Diabetes

  • Identification data

    Identifier: imarina:9452195
    Authors:
    Jurek, Joanna MichalinaZablocka-Sowinska, KatarzynaMestres, Helena ClaveroGutierrez, Leyre ReyesCamaron, JavierAuguet, Teresa
    Abstract:
    Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a public health concern, linked with immune-metabolic dysfunction. While lifestyle and dietary modifications remain the cornerstone of MASLD management, the optimal dietary approach remains uncertain. Objectives: This systematic review aims to investigate the impact of model dietary patterns on metabolic outcomes in patients with MASLD and evaluate their effects in individuals with coexisting metabolic conditions, such as obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM). Methods: To conduct the review, PubMed, Scopus, Google Scholar, Cochrane CENTRAL, and ClinicalTrials.gov databases were searched for Randomized Controlled Trials (RCTs) on the adult population, published between January 2019 and September 2024, following PRISMA principles. The quality of the included RCTs was assessed qualitatively based on study characteristics. Results: The main findings of this review demonstrated that the use of interventions with dietary model based on Mediterranean diet (MED) and intermittent fasting (IF) approaches, such as alternative-day fasting (ADF) and time-restricted feeding regimens (TRF) may have potential in reducing body weight, BMI, and waist circumference, with additional benefits of improving glycemic control and reducing inflammation. The effects on hepatic functions, although limited, may be linked with reduced enzyme activity and liver stiffness. Additionally, the use of lacto-ovo-vegetarian diet (LOV-D) and the Dietary Approaches to Stop Hypertension (DASH) diet may offer additional health benefits, including blood pressure management. Conclusions: This review suggests that MED and IF-based strategies may reduce BW, improve glycemic control, and lower inflammation, wit
  • Others:

    Author, as appears in the article.: Jurek, Joanna Michalina; Zablocka-Sowinska, Katarzyna; Mestres, Helena Clavero; Gutierrez, Leyre Reyes; Camaron, Javier; Auguet, Teresa
    Department: Medicina i Cirurgia
    URV's Author/s: Auguet Quintillà, Maria Teresa
    Keywords: Adherence Adult Adults Comorbidity Dash diet Diabetes mellitus, type 2 Diet, mediterranean Dietary intervention Fasting Fatty liver Female Humans Male Masld/non-alcoholic fatty liver disease Mediterranean Mediterranean diet Metabolic outcomes Metabolic syndrome Middle aged Non-alcoholic fatty liver disease Obesity Randomized controlled trials as topic Ris Systematic revie Systematic review Type 2 diabetes Weight
    Abstract: Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a public health concern, linked with immune-metabolic dysfunction. While lifestyle and dietary modifications remain the cornerstone of MASLD management, the optimal dietary approach remains uncertain. Objectives: This systematic review aims to investigate the impact of model dietary patterns on metabolic outcomes in patients with MASLD and evaluate their effects in individuals with coexisting metabolic conditions, such as obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM). Methods: To conduct the review, PubMed, Scopus, Google Scholar, Cochrane CENTRAL, and ClinicalTrials.gov databases were searched for Randomized Controlled Trials (RCTs) on the adult population, published between January 2019 and September 2024, following PRISMA principles. The quality of the included RCTs was assessed qualitatively based on study characteristics. Results: The main findings of this review demonstrated that the use of interventions with dietary model based on Mediterranean diet (MED) and intermittent fasting (IF) approaches, such as alternative-day fasting (ADF) and time-restricted feeding regimens (TRF) may have potential in reducing body weight, BMI, and waist circumference, with additional benefits of improving glycemic control and reducing inflammation. The effects on hepatic functions, although limited, may be linked with reduced enzyme activity and liver stiffness. Additionally, the use of lacto-ovo-vegetarian diet (LOV-D) and the Dietary Approaches to Stop Hypertension (DASH) diet may offer additional health benefits, including blood pressure management. Conclusions: This review suggests that MED and IF-based strategies may reduce BW, improve glycemic control, and lower inflammation, with potential benefits for hepatic function. Further long-term studies are needed to confirm these effects and underlying mechanisms, which will allow for the optimization of protocols and ensure their safety in MASLD.
    Research group: GRUP D'ESTUDI DE MALALTIES METABÒLIQUES ASSOCIADES A INSULINRESISTÈNCIA
    Thematic Areas: Biotecnología Ciência de alimentos Ciências agrárias i Ciências biológicas i Ciências biológicas ii Ciências biológicas iii Economia Educação física Enfermagem Engenharias ii Engenharias iv Farmacia Food science Interdisciplinar Medicina i Medicina ii Medicina iii Medicina veterinaria Nutrição Nutrition & dietetics Nutrition and dietetics Planejamento urbano e regional / demografia Psicología Química Saúde coletiva Zootecnia / recursos pesqueiros
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: mariateresa.auguet@urv.cat
    Author identifier: 0000-0003-0396-6428 https://orcid.org/0000-0003-0396-6428
    Record's date: 2025-04-30
    Paper version: info:eu-repo/semantics/publishedVersion
    Paper original source: Nutrients. 17 (7): 1257-
    APA: Jurek, Joanna Michalina; Zablocka-Sowinska, Katarzyna; Mestres, Helena Clavero; Gutierrez, Leyre Reyes; Camaron, Javier; Auguet, Teresa (2025). The Impact of Dietary Interventions on Metabolic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Comorbid Conditions, Including Obesity and Type 2 Diabetes. Nutrients, 17(7), 1257-. DOI: 10.3390/nu17071257
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2025
    Publication Type: Journal Publications
  • Keywords:

    Food Science,Nutrition & Dietetics,Nutrition and Dietetics
    Adherence
    Adult
    Adults
    Comorbidity
    Dash diet
    Diabetes mellitus, type 2
    Diet, mediterranean
    Dietary intervention
    Fasting
    Fatty liver
    Female
    Humans
    Male
    Masld/non-alcoholic fatty liver disease
    Mediterranean
    Mediterranean diet
    Metabolic outcomes
    Metabolic syndrome
    Middle aged
    Non-alcoholic fatty liver disease
    Obesity
    Randomized controlled trials as topic
    Ris
    Systematic revie
    Systematic review
    Type 2 diabetes
    Weight
    Biotecnología
    Ciência de alimentos
    Ciências agrárias i
    Ciências biológicas i
    Ciências biológicas ii
    Ciências biológicas iii
    Economia
    Educação física
    Enfermagem
    Engenharias ii
    Engenharias iv
    Farmacia
    Food science
    Interdisciplinar
    Medicina i
    Medicina ii
    Medicina iii
    Medicina veterinaria
    Nutrição
    Nutrition & dietetics
    Nutrition and dietetics
    Planejamento urbano e regional / demografia
    Psicología
    Química
    Saúde coletiva
    Zootecnia / recursos pesqueiros
  • Documents:

  • Cerca a google

    Search to google scholar